Ellington Credit (EARN): Payout Cut to $0.05, NAV $4.04, Fees
Some links pay us a referral fee; each one says so. Disclosure
Filing alert · free
An email when Ellington Credit files with the SEC
An email the day Ellington Credit files something new, with the link to the document on the SEC site.
Quick answer
Ellington Credit Company (NYSE: EARN, SEC CIK 0001560672), a closed-end fund that owns CLO debt and equity, reported net asset value (NAV) of $4.04 a share at September 30, 2026 in its semiannual report (Form N-CSRS, filed November 20, 2026, accession 0001628280-26-075228). That is down from $6.08 on March 31, 2025, the day before it converted from a mortgage REIT. On November 19, 2026 the Board declared $0.05 a share for the payment due January 29, 2027, after $0.08 a month: a 37.5% cut (our arithmetic). Net investment income was $0.33 a share in the six months against $0.48 of distributions, 69% (our arithmetic), and the report books all $0.48 as return of capital. In the fund's own October 2026 monthly update the shares closed at $3.48, 10.3% below the estimated NAV.
Key takeaways
- The payout was reset on November 19, 2026. The Board declared $0.05 a share, payable January 29, 2027 to holders of record on December 31, 2026, after $0.08 a month through the November 2026 declaration. That is $0.60 a share a year against $0.96 (our arithmetic). The fund says the new $0.15 a quarter is below the $0.17 of net investment income (NII) per share earned in the quarter to September 30, 2026.
- The old payout was not covered by NII. NII was $0.33 a share against $0.48 of distributions in the six months to September 30, 2026 (69%, our arithmetic) and $0.74 against $0.96 in the year to March 31, 2026 (77%, our arithmetic). The financial statements show all of those distributions as return of capital, and say the tax character is only known after the tax return.
- NAV per share fell from $6.08 on March 31, 2025 to $4.04 on September 30, 2026, 33.6% (our arithmetic), while $1.44 a share of distributions was paid in between (our arithmetic: $0.96 in the year to March 2026 plus $0.48 in six months). Adding the payouts back, NAV plus distributions is $5.48, 9.9% under $6.08 (our arithmetic, no reinvestment).
- Price and NAV changed places. In every month-end we could read from December 2025 to August 2026 the fund's updates show the shares above NAV (premiums of 1.5% to 11.3%). On September 30, 2026 the close was $4.04, equal to NAV. On October 31, 2026 it was $3.48 against an estimated NAV of $3.85 to $3.91, a 10.3% discount as the fund states it.
- The fee table shows 12.63% of average NAV a year: 1.46% management, 2.82% performance fee, 5.38% interest on borrowed money and 2.97% other expenses, with no sales load. On $100,000 of NAV that is $12,630 a year (our arithmetic). In the six months to September 30, 2026 the annualized ratio was 14.99%.
- CLO debt was $146.4 million (44.1% of investments) and CLO equity $185.6 million (55.8%) at fair value on September 30, 2026, against a cost of $386.8 million for all investments, so fair value was 86% of cost (our arithmetic). The largest position, the equity of Bridge Street CLO V, was $13.5 million, 8.48% of net assets.
- Debt was $202.1 million, $148.1 million of reverse repurchase agreements and $54.0 million of 8.50% notes due 2031, 1.27 times net assets. The fund sold 1,848,608 shares in six months at about a 4% premium to NAV. It has a $125 million at-the-market program and a $20 million buyback authorization, and the N-CSRS says it has used neither.
CSV · 203 rows
Ellington Credit (EARN): NAV by quarter and month, price against NAV, distributions, fees, CLO portfolio, debt and share issuance
203 rows from the November 20, 2026 semiannual report (Form N-CSRS), the May 29, 2026 annual report (Form N-CSR), the November 19, 2026 8-Ks, earlier earnings 8-Ks, monthly Form 497AD updates and the conversion filings. Form and accession number on every row.
What the three November 2026 filings are
Three filings of November 19 and 20, 2026 are the reason for this page. The first Form 8-K of November 19 (accession 0001628280-26-075129) is only the distribution declaration: $0.05 a share, payable January 29, 2027 to holders of record on December 31, 2026. The second (accession 0001628280-26-075131) furnishes the earnings release for the quarter ended September 30, 2026, which the fund calls its second fiscal quarter: NAV $4.04, NII $6.7 million or $0.17 a share, GAAP net income $3.7 million or $0.09 a share. The third is the N-CSRS of November 20, 2026, the unaudited report for the six months from April 1 to September 30, 2026, with the schedule of investments, financial statements, notes and financial highlights.
The release also says what the Board did, in its own words: “Our Board of Trustees has reset our monthly distribution rate to $0.05 per share, or $0.15 per quarter, a level supported by our current NII.” The report adds that the fund's Board “reset the monthly common share distribution from $0.08 to $0.05 per share” and that the new rate is below the $0.17 of NII per share earned in the quarter to September 30, 2026.
It is a different company from Ellington Financial (EFC), which we cover in Ellington Financial (EFC) stock: dividend and book value. This page is only about Ellington Credit Company, ticker EARN.
From mortgage REIT to CLO fund: what the conversion filings say
The N-CSRS says the company “was initially formed as a real estate investment trust (“REIT”) on August 2, 2012” and that on April 1, 2025 it “converted to a Delaware closed-end fund registered under the Investment Company Act of 1940”. EDGAR's record shows the registrant filed as Ellington Residential Mortgage REIT until April 12, 2024. Shareholders approved the conversion at a special meeting on January 17, 2025: 32,900,266 votes for the change of legal form against 1,233,833 against, and 32,676,006 for the new investment advisory agreement against 1,433,619 (Form 8-K, accession 0001560672-25-000013). The April 1, 2025 press release (Form 8-K, accession 0001560672-25-000039) says the fund planned to sell its remaining Agency MBS pools, buy more corporate CLOs and operate as a regulated investment company, and to move its fiscal year end to March 31, the day before the conversion.
For a holder of the old stock this is the whole change: a company that owned Agency mortgage bonds and borrowed against them, like the ones in our AGNC and Annaly dividend and book value page, became a fund that buys the debt and equity of CLOs, which are pools of loans to companies with below-investment-grade credit. The N-CSRS describes the strategy as “investing primarily in the mezzanine debt and equity tranches of corporate collateralized loan obligations”. Its closest peers on our site are Oxford Lane Capital (OXLC), Oxford Park Income Fund and Eagle Point Credit (ECC).
The payout: nine declarations and a reset
The N-CSRS lists every distribution the Board declared from April 7, 2026 through November 19, 2026.
| Declared | Record date | Payment date | Per share |
|---|---|---|---|
| April 7, 2026 | April 30, 2026 | May 29, 2026 | $0.08 |
| May 7, 2026 | May 29, 2026 | June 30, 2026 | $0.08 |
| June 8, 2026 | June 30, 2026 | July 31, 2026 | $0.08 |
| July 8, 2026 | July 31, 2026 | August 31, 2026 | $0.08 |
| August 10, 2026 | August 31, 2026 | September 30, 2026 | $0.08 |
| September 8, 2026 | September 30, 2026 | October 30, 2026 | $0.08 |
| October 7, 2026 | October 30, 2026 | November 30, 2026 | $0.08 |
| November 5, 2026 | November 30, 2026 | December 31, 2026 | $0.08 |
| November 19, 2026 | December 31, 2026 | January 29, 2027 | $0.05 |
On 39,456,092 shares, $0.08 a month is about $3.16 million (our arithmetic), which matches the $3,156 thousand “distributions payable” on the September 30, 2026 balance sheet. At $0.05 it is about $1.97 million a month, or $23.7 million a year against $37.9 million (our arithmetic), before any change in the share count.
Did NII cover it? Quarter by quarter
Each earnings release states the quarter's NII per share and says the NAV figure “includes the effects of distributions of $0.24 per share for the quarter”. The coverage column is our arithmetic. “Adjusted” NII is a non-GAAP measure the company defines in its releases; the GAAP figure is the one in the financial statements.
| Quarter ended | NII per share | Adjusted NII per share | Distributions for the quarter | NII over distributions (our arithmetic) |
|---|---|---|---|---|
| June 30, 2025 | $0.17 | $0.18 | $0.24 | 71% |
| September 30, 2025 | $0.23 | $0.23 | $0.24 | 96% |
| December 31, 2025 | $0.21 | $0.21 | $0.24 | 88% |
| March 31, 2026 | $0.13 | $0.19 | $0.24 | 54% |
| June 30, 2026 | $0.16 | $0.15 | $0.24 | 67% |
| September 30, 2026 | $0.17 | $0.17 | $0.24 | 71% |
| New rate, per quarter | NII of $0.17 (quarter to September 30, 2026) | $0.15 | 113% |
Two readings. First, the fund came close in the quarter to September 30, 2025, when the release says it “achieved full dividend coverage from net investment income in September”, and then did not repeat it: GAAP NII per share fell to $0.13 in the quarter to March 31, 2026 and was $0.17 in the latest quarter. Second, the new rate is covered by that latest quarter's NII, but one quarter is not a trend, and the fund's own report says “Distributions are not guaranteed and should not be viewed as equivalent to NII.”
The cash the CLOs paid was higher than NII: the N-CSRS says the fund received $32.0 million, or $0.84 a share, of recurring cash distributions from its CLO portfolio in the six months, against $0.33 of NII per share. It adds that these cash distributions may include amounts characterized as return of capital, so they are not income.
NAV per share and price, from the conversion to October 2026
NAV at each quarter-end, from the earnings releases and the N-CSR and N-CSRS:
| Date | NAV per share | Change from previous row (our arithmetic) | Source |
|---|---|---|---|
| March 31, 2025 | $6.08 | N-CSR, financial highlights | |
| June 30, 2025 | $6.12 | up 0.7% | 8-K, accession 0001560672-25-000082 |
| September 30, 2025 | $5.99 | down 2.1% | 8-K, accession 0001628280-25-053254 |
| December 31, 2025 | $5.19 | down 13.4% | 8-K, accession 0001628280-26-014689 |
| March 31, 2026 | $4.09 | down 21.2% | 8-K, accession 0001628280-26-036741 |
| June 30, 2026 | $4.18 | up 2.2% | 8-K, accession 0001628280-26-056312 |
| September 30, 2026 | $4.04 | down 3.3% | N-CSRS and 8-K, accession 0001628280-26-075131 |
The two big falls are the quarters to December 2025 (GAAP net loss of $0.56 a share) and March 2026 (net loss of $0.86 a share), which the company attributes in its releases to a weak CLO equity market. The N-CSR financial highlights for the year to March 31, 2026 show where the $1.99 went (our arithmetic): $6.08 plus $0.74 of NII, minus $1.77 of net realized and unrealized losses, minus $0.96 of distributions, gives $4.09.
| Per share | Year to March 31, 2026 | Six months to September 30, 2026 |
|---|---|---|
| NAV at start | $6.08 | $4.09 |
| Net investment income | $0.74 | $0.33 |
| Net realized and unrealized gain (loss) | ($1.77) | $0.09 |
| Distributions (all return of capital on the books) | ($0.96) | ($0.48) |
| Effect of share issuance | none | $0.01 |
| NAV at end | $4.09 | $4.04 |
| Total return on NAV | (18.89%) | 10.62% (not annualized) |
| Per share market value, end of period | $4.43 | $4.04 |
Price against NAV, month by month
The fund files a monthly NAV and portfolio update (Form 497AD) with an estimated NAV range, the closing price on the last trading day and the premium or discount to the midpoint of that range. We quote only prices that appear in the fund's filings. The estimates are the fund's and “subject to change” when quarter-end valuations are finished; the official quarter-end figures are in the table above.
| Month-end | Estimated NAV per share | Closing price | Premium or (discount), as the fund states it |
|---|---|---|---|
| March 31, 2025 | $6.08 (N-CSR) | $5.41 (N-CSR) | (11.0%) (our arithmetic) |
| April 30, 2025 | $5.85 - $5.91 | $5.46 | (7.1%) |
| May 31, 2025 | $6.04 - $6.10 | $5.62 | (7.4%) |
| June 30, 2025 | $6.09 - $6.15 | $5.75 | (6.0%) |
| August 31, 2025 | $6.07 - $6.13 | $5.71 | (6.4%) |
| September 30, 2025 | $5.96 - $6.02 | $5.45 | (9.0%) |
| October 31, 2025 | $5.71 - $5.77 | $5.09 | (11.3%) |
| December 31, 2025 | $5.16 - $5.22 | $5.27 | 1.5% premium |
| January 31, 2026 | $5.01 - $5.07 | $5.46 | 8.3% premium |
| February 28, 2026 | $4.46 - $4.52 | $4.89 | 8.9% premium |
| March 31, 2026 | $4.09 (N-CSR) | $4.43 (N-CSR) | 8.3% premium (our arithmetic) |
| May 31, 2026 | $4.23 - $4.29 | $4.74 | 11.3% premium |
| June 30, 2026 | $4.15 - $4.21 | $4.42 | 5.7% premium |
| July 31, 2026 | $4.20 - $4.26 | $4.32 | 2.1% premium |
| August 31, 2026 | $4.13 - $4.19 | $4.37 | 5.0% premium |
| September 30, 2026 | $4.01 - $4.07 | $4.04 | 0.0% |
| October 31, 2026 | $3.85 - $3.91 | $3.48 | (10.3%) |
Three months (July 2025, November 2025 and April 2026) are missing because the stock-data block of those updates is not readable as text in the filings we saved; we did not fill them from elsewhere. The reading is simple. For most of 2025 the shares sat 6% to 11% below NAV, in the winter and spring of 2026 they traded at a premium, and in October 2026 they went back to a discount. The October update also states a “current distribution rate” of 27.6% on the $0.08 monthly payout. At the new $0.05 the rate on that $3.48 close would be 17.2% (our arithmetic: $0.60 over $3.48), and 14.9% on the $4.04 NAV.
The price drop shows up in the dividend reinvestment plan too. The plan issues shares at a 5% discount to the market price, and the issuance price on the six record dates from April 30 to September 30, 2026 fell from $4.50 to $4.20, $4.10, $4.15, $3.84 and $3.31. The last one implies a market price of about $3.48 (our arithmetic), the same as the October 31 close.
What the fund owns on September 30, 2026
| Category | Amortized cost ($ thousands) | Fair value ($ thousands) | Fair value over cost (our arithmetic) | Share of investments |
|---|---|---|---|---|
| U.S. CLO debt | 127,443 | 119,317 | 93.6% | 35.9% |
| European CLO debt | 31,461 | 27,097 | 86.1% | 8.2% |
| Total CLO debt | 158,904 | 146,414 | 92.1% | 44.1% |
| U.S. CLO equity | 221,892 | 182,530 | 82.3% | 54.9% |
| European CLO equity | 5,557 | 3,043 | 54.8% | 0.9% |
| Total CLO equity | 227,449 | 185,573 | 81.6% | 55.8% |
| Other investments | 403 | 467 | 0.1% | |
| Total investments | 386,756 | 332,454 | 86.0% | 100.0% |
CLO equity is the part of a CLO that takes the first losses and gets whatever cash is left after the CLO pays its debt; CLO debt, here the mezzanine tranches, is paid before it. At September 30, 2026 the fund's CLO equity was 116.32% of its net assets, because the fund also borrows (the schedule's percentage column is against net assets, so positions add to more than 100%).
The fund says its CLO portfolio had a weighted average yield of 18.3% on fair value at September 30, 2026. That is a projected figure on its own valuations, not a payout rate. The reported GAAP yield on amortized cost was lower, 12.4% for the six months, and the release puts the quarter at 12.9%.
The largest positions
From the consolidated schedule of investments (cost and fair value in $ thousands; the last column is percent of net assets of $159,536 thousand):
| Position | Type | Cost | Fair value | Percent of net assets |
|---|---|---|---|---|
| Bridge Street CLO V Ltd. | CLO equity, effective yield 13.52%, maturity April 20, 2038 | 14,183 | 13,530 | 8.48% |
| Voya CLO 2024-3, Ltd. | CLO equity, effective yield 14.57%, maturity July 20, 2037 | 7,120 | 6,777 | 4.25% |
| Apidos CLO XXXIV | CLO equity, effective yield 10.39%, maturity January 20, 2039 | 6,938 | 6,649 | 4.17% |
| Empower CLO 2022-1, LLC | CLO equity, effective yield 12.73% | 11,045 | 6,224 | 3.90% |
| New Mountain CLO 2 Ltd | CLO equity, effective yield 16.88%, maturity April 15, 2034 | 7,305 | 5,697 | 3.57% |
| Bain Capital Credit CLO 2017-2, Limited | CLO debt, Class ER3, SOFR + 7.34%, due July 25, 2037 | 6,560 | 6,074 | 3.81% |
| First Eagle BSL CLO 2019-1 Ltd. | CLO debt, Class D, SOFR + 7.96%, due January 20, 2033 | 5,524 | 5,600 | 3.51% |
| Fortress Credit BSL IX Limited | CLO debt, Class ER, SOFR + 7.60%, due October 20, 2033 | 4,950 | 4,842 | 3.03% |
The five largest equity positions add up to $38.9 million of fair value, 11.7% of total investments (our arithmetic). Bridge Street alone is 4.1% of investments (our arithmetic) and has a fair value below its cost, as does every position in the table except the First Eagle debt note. The Empower position is carried at 56% of cost (our arithmetic, $6,224 thousand over $11,045 thousand).
What sits under the CLOs
The N-CSRS also gives a look-through to the loans inside the CLOs, estimated by the fund from trustee reports and manager data. As of September 30, 2026 it counts 1,922 unique underlying loan issuers and 3,200 loans, a floating-rate spread of 3.02%, a junior over-collateralization cushion of 4.34% on its equity tranches, 95.5% senior secured loans, an average loan rating of B+/B and a 4.4-year average maturity. The exposure is 91% U.S. dollar and 9% euro. The fund notes that the U.S. leveraged loan payment default rate over twelve months fell from 1.4% to 0.6% over the six months, while the European one rose from 1.4% to 2.2%, and says that over the six months its “small allocation to European CLO equity generated a net loss”; that slice is carried at 54.8% of cost (our arithmetic), against 86.1% for European CLO debt.
Debt, hedges and leverage
| Item | September 30, 2026 | Terms in the N-CSRS |
|---|---|---|
| Reverse repurchase agreements | $148.1 million | Eight counterparties, weighted average rate 5.09%, 62 days to maturity on average; $241.0 million of CLOs pledged |
| 8.50% senior notes due March 30, 2031 (NYSE: ELLA) | $54.0 million principal | Issued March 2026; the fund may redeem from March 30, 2028 at par plus accrued interest |
| Total debt | $202.1 million | Down from $220.3 million at March 31, 2026 |
| Debt-to-equity | 1.27 to 1 | 1.43 to 1 at March 31, 2026 |
| Asset coverage on the notes | 670% | Section 18 of the 1940 Act sets a 300% floor for senior debt securities, as the report explains |
| Weighted average funding cost | 6.00% | On the fund's borrowings |
| Credit hedges | $170.5 million of high-yield CDX equivalents | $187.5 million at March 31, 2026; the fund says they mainly protect against more severe dislocations |
The largest single counterparty exposure is RBC Capital Markets, with $26.0 million at risk, 16.3% of NAV, followed by BNP Paribas Securities at 13.2% and Mizuho at 11.2%. The reverse repos run 30 to 364 days, so the financing is renewed often, and the report says counterparties can make margin calls when the pledged CLOs lose value. Interest expense was $6.0 million of the $12.0 million of total expenses in the six months (our arithmetic: 50%).
Fees: what a shareholder bears
The fund's own “Summary of Fees and Expenses” in the annual report (Form N-CSR, filed May 29, 2026, accession 0001628280-26-039063) gives a table of annual expenses as a percent of average NAV of common equity.
| Line | Percent of average NAV | On $100,000 of NAV (our arithmetic) |
|---|---|---|
| Management fee (1.50% of NAV, adjusted) | 1.46% | $1,460 |
| Performance fee (17.5%) | 2.82% | $2,820 |
| Interest payments and fees on borrowed funds | 5.38% | $5,380 |
| Other expenses | 2.97% | $2,970 |
| Total annual fund expenses | 12.63% | $12,630 |
| Sales load | none | $0 |
The semiannual financial highlights show the same measure for the six months to September 30, 2026, annualized: 14.99% of average net assets, or 11.71% before performance fees and 4.24% before performance fees and interest. For the year to March 31, 2026 it was 11.47%, 8.65% and 4.67%. The fund borrows to hold CLOs, so interest is the largest single cost, and a holder bears it through NAV.
How the two fees work, from Note 8 of the N-CSRS: the Adviser gets a base management fee of 1.50% a year of the fund's NAV, payable quarterly in arrears, and a performance fee that is “subject to a hurdle rate of 2.00% per quarter, or 8.00% per annum”, with a catch-up, so that once pre-fee NII passes 121.21% of the hurdle the Adviser takes 17.5% of it. The fee is calculated on “Pre-Performance Fee Net Investment Income”, which the report says “does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation”, and there is “no claw back of amounts previously paid”. In the six months the fund incurred $1.2 million of base fees and $2.6 million of performance fees. In the same six months it booked net realized losses of $2.1 million on investments and $6.4 million on derivatives (statement of operations), and NAV per share ended $0.05 lower than where the period began. That is how the contract is written, not a finding, but it is why “NII after fees” and “total return” can tell different stories.
Shares: issuance, the at-the-market program and the buyback
| Tool | Size | Status in the N-CSRS |
|---|---|---|
| Committed equity facility with Citizens JMP (June 2026) | Up to 7.5 million shares over 36 months | 1,848,608 shares issued in six months for $8.0 million net, about a 4% weighted average premium to NAV; about 5.7 million shares of authorization left |
| At-the-market program (equity distribution agreement of October 23, 2026, Form 8-K accession 0001628280-26-067429) | Up to $125 million, agents paid up to 2.0% of the gross sales price | No shares issued under it |
| Share repurchase program (Board authorization October 9, 2026, Form 8-K accession 0001628280-26-066048) | Up to $20 million in the open market until October 9, 2027 | No shares repurchased; the report says “We have not repurchased any shares under the program to date” |
| Dividend reinvestment plan | Shares at a 5% discount to the then-current market price | 27,915 shares issued in six months |
Shares outstanding went from 37,579,569 at March 31, 2026 to 39,456,092 at September 30, 2026, up 5.0% (our arithmetic). The prospectus filed with the September 1, 2026 registration statement (Form N-2) says the fund's offering price per common share “will not be less than the net asset value per share at the time the Fund makes the offering” except in listed cases such as a rights offering or with the consent of a majority of shareholders. With the shares at $3.48 against an estimated NAV of $3.85 to $3.91 on October 31, 2026, our reading of that sentence is that new shares cannot be sold through the at-the-market program at that price; the buyback is the tool that fits a discount, and the report says the fund will be “highly selective”.
Tax: how the filings describe the payout
The fund says it intends to qualify as a regulated investment company and has made an election under Section 475(f) of the Code to mark most of its investments to market for tax purposes. Note 7 says that, as a result, “distributions to shareholders generally will be taxable as ordinary income, although a portion of such distributions may be designated as long-term capital gain or qualified dividend income, or may constitute a return of capital.” The financial statements book all distributions as return of capital ($18,477 thousand in the six months and $36,065 thousand in the year to March 31, 2026; the estimated tax character for the year to March 2026 was $36,063 thousand of return of capital, no ordinary income and no capital gain). The report says the final character is not known until the tax return. We did not find a Section 19(a) notice of the sources of a distribution on EDGAR for the fund; the shareholder tax statement after year end is the document that counts, and it is not in the filings.
What a holder can read and watch
| Date | What | Why it matters |
|---|---|---|
| December 12, 2026 | 14,991 restricted shares held by partially dedicated personnel vest | A small share count change disclosed in the N-CSRS |
| December 31, 2026 | Record date for the $0.05 distribution | You must hold the shares on this date to receive it on January 29, 2027 |
| January 29, 2027 | Payment date of the first $0.05 distribution | No declaration beyond it was on EDGAR on November 21, 2026 |
| Mid-December 2026 (pattern) | Monthly NAV update (Form 497AD) for November 2026 | Filed November 18, October 16 and September 17, 2026 for the prior months |
| Early March 2027 (pattern) | Earnings release for the quarter to December 31, 2026 | The release for the same quarter a year earlier was filed March 4, 2026 |
| Late May 2027 (pattern) | Annual report (Form N-CSR) for the year to March 31, 2027 | The last one was filed May 29, 2026 |
| October 9, 2027 | End of the $20 million buyback authorization | Unless extended or ended earlier |
| March 30, 2028 | First date the fund may redeem the 8.50% notes | Maturity is March 30, 2031 |
Dates marked “pattern” are our reading of past EDGAR filing dates, not announced dates.
What a reader can do with this
This is a checklist built from the filings, not a recommendation.
- Use the new rate, not the old one. Any yield quoted from the $0.08 monthly payout, including the 27.6% in the October 2026 update, is out of date for payments after January 2027. At $0.05 the annual rate is $0.60 a share.
- Read coverage two ways. GAAP NII covered 71% of the old quarterly payout in the latest quarter, and 113% of the new one (our arithmetic). The cash the CLOs paid, $0.84 a share in six months, includes return of capital and is not income.
- Compare price with NAV on the same day. The fund files an estimate each month; the filing date is mid-month, so the price you see on a screen is newer than the NAV. The last official NAV is $4.04 at September 30, 2026.
- Know what you pay. The fee table shows 12.63% of NAV a year, $12,630 on $100,000, and most of the cost is the interest on borrowed money plus a performance fee that does not look at capital losses.
- Look at the concentration. The five largest CLO equity positions are 11.7% of investments, and CLO equity is 55.8% of investments at fair value, carried at 81.6% of its cost (our arithmetic).
- Check the share count. The fund can issue shares and has authority to buy them back; both are optional and the N-CSRS says neither the at-the-market program nor the buyback had been used.
- Taxes. The books show return of capital; the tax statement after year end decides the character. See our BDC explainer for how fund distributions are reported differently from qualified dividends.
This is analysis of public documents, not investment, legal or tax advice. If EARN, or a mix of CLO funds that cut their payouts, is a large share of your income or portfolio, a conversation with a qualified adviser about how it fits may be worth having.
FAQ
Sources: Ellington Credit Company (SEC CIK 0001560672): Form N-CSRS for the six months ended September 30, 2026 (accession 0001628280-26-075228, filed November 20, 2026); Forms 8-K of November 19, 2026 (accessions 0001628280-26-075129 and 0001628280-26-075131); Form N-CSR for the year ended March 31, 2026 (accession 0001628280-26-039063); Forms 8-K of January 21, 2025, April 1, 2025, August 19, 2025, November 19, 2025, March 4, 2026, May 20, 2026, August 12, 2026, October 16, 2026 and October 27, 2026; Form N-2 filed September 1, 2026 (accession 0001999371-26-019487); Forms 497AD monthly NAV and portfolio updates filed May 20, 2025 to November 18, 2026. Prices and premiums are the fund's own, from its filings. This is analysis of public documents, not investment, legal or tax advice.